Literature DB >> 6176335

Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes.

R B Herberman, J R Ortaldo, A Mantovani, D S Hobbs, H F Kung, S Pestka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6176335     DOI： 10.1016/0008-8749(82)90208-8

Source DB:  PubMed          Journal:  Cell Immunol        ISSN： 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  23 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.

Authors:  Y K Yoo; J B Gavaler; K Chen; T L Whiteside; D H van Thiel
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

Review 3.  Rationale for immunotherapy of renal cell carcinoma.

Authors:  R Heicappell; R Ackermann
Journal:  Urol Res       Date:  1990

4.  Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity.

Authors:  Kirstine Lavrsen; Caroline B Madsen; Morten G Rasch; Anders Woetmann; Niels Ødum; Ulla Mandel; Henrik Clausen; Anders E Pedersen; Hans H Wandall
Journal:  Glycoconj J       Date:  2012-08-10       Impact factor: 2.916

5.  Failure of intraventricular gammaglobulin and alpha interferon for persistent encephalitis in congenital hypogammaglobulinaemia.

Authors:  D M Roberton; I Jack; W Joshi; F Law; C S Hosking
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

6.  Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.

Authors:  D Flieger; A S Hoff; T Sauerbruch; I G Schmidt-Wolf
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

7.  Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C.

Authors:  H Unoki; A Moriyama; A Tabaru; A Masumoto; M Otsuki
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

8.  Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.

Authors:  J M Pelham; J D Gray; G R Flannery; M V Pimm; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

Review 10.  Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

Authors:  Ruth Whittington; Diana Faulds
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.